European Medicines Agency (EMA) updated the EudraCT homepage by providing the following update over the What’s New section on July 29, 2022:
There are a considerable amount of clinical trials that are currently marked as ‘ongoing’ in the EudraCT database. In view of the upcoming transition to CTIS, sponsors are encouraged to verify the overall status of their clinical trials posted on EU CTR. An end of trial form will need to be submitted to the National Competant Authority (NCA) for the ‘completed’ and ‘prematurely ended’ clinical trials. The sponsors are requested to post results for these clinical trials as per European Commission guideline 2012/C 302/03.